NLGN3 and central nervous system cancer: To confirm the efficiency of the applied shRNA, we showed that Gαi1 and Gαi3 proteins were silenced in Gαi1/3 DshRNA-expressing P1 glioma cells (with NLGN3 treatment, at 72h) (Figure 5D).